989 recalls tagged with “adult product”.
LeMaitre Vascular recalled 28 Artegraft Collagen Vascular Grafts distributed nationwide in 17 states. The grafts use bovine carotid arteries sourced from a supplier not reviewed by the appropriate regulatory authority. Patients and healthcare providers should stop using the device immediately and contact LeMaitre Vascular for instructions.
Fagron Compounding Services recalls 109,320 sterile single-dose bevacizumab syringes nationwide due to lack of assurance of sterility. Healthcare providers and patients should stop using the product immediately. Contact Fagron Compounding Services or a healthcare provider for guidance. The recall was issued on 2025-08-29 and remains active as of 2025-09-24.
ConvaTec recalled 80,980 DuoDERM Extra Thin wound dressings distributed nationwide in the United States. The dressings may contain foreign matter, which could compromise wound care. Healthcare providers and patients should stop using the dressings and follow recall instructions.
Baxter Healthcare recalled 2,304 CLEARLINK System Extension Sets distributed nationwide in the United States. The IV extension set may leak, creating a risk to patients. Stop using the device immediately and follow recall instructions from Baxter or your healthcare provider.
Baxter Healthcare recalls 49,200 CONTINU-FLO IV Solution Sets distributed nationwide in the United States. IV sets may leak. Healthcare facilities and patients should stop using the device immediately and follow Baxter's recall instructions.
Northeast Scientific recalled 795 NES Reprocessed 0.9mm RX Turbo Elite Laser Atherectomy Catheters nationwide. The device is not cleared for marketing in the United States. The recall cites breaches in sterile barrier packaging that could compromise sterility. Hospitals and providers should stop using the device immediately and follow manufacturer instructions.
Northeast Scientific Inc. has issued a recall for 616 units of the NES Reprocessed Turbo-Elite Laser Atherectomy Catheter, Model R-417-156. The FDA-listed recall cites breaches in sterile barrier packaging that could compromise sterility. The devices were distributed nationwide in the United States to CA, FL, IL, KS, LA, MD, MI, MO, NC, NJ, NM, NV, NY, PA, TN, TX, and VA. Patients should not be in
Baxter Healthcare Corp. is recalling 18,720 CLEARLINK System Non-DEHP Conti-Flo Soln Sets sold nationwide in the United States. The IV sets may leak, potentially compromising therapy. Patients and healthcare providers should stop using the device immediately and contact Baxter Healthcare for instructions.
Baxter Healthcare recalled 136,512 CLEARLINK System Solution Set DUO-VENT IV sets distributed nationwide in the United States after detecting a leak risk. The Luer Activated Valve design may leak, potentially compromising IV administration. Hospitals and patients should stop using the device immediately and follow Baxter recall instructions.
Northeast Scientific recalled 561 units of NES Reprocessed 0.9mm OTW Turbo Elite Laser Atherectomy Catheter. The recall covers all lots within shelf life ending before August 29, 2026. The hazard is breaches in sterile barrier packaging that could compromise sterility. Stop using the device and follow manufacturer instructions for return or replacement.
ImaCor recalls 45 CLT-010 miniaturized TEE probes nationwide in five states after a production assembly error risks reversed articulation. The device is used with ImaCor model ZHH and Mobile Ultrasound. Stop using the device immediately and follow the manufacturer’s recall instructions.
Northeast Scientific recalled 165 units of the NES Reprocessed 1.7mm OTW Turbo Elite Laser Atherectomy Catheter sold nationwide in the United States. The recall cites the potential breach of sterile barrier packaging that could compromise sterility. The device is not cleared for marketing in the U.S. and has a high-risk hazard designation. Patients and healthcare providers should stop using the产品,
Baxter Healthcare Corporation recalled 958,351 CLEARLINK CONTINU-FLO IV sets due to a leak risk. The non-vented sets feature three Luer activated valves and a Backcheck Valve. Distribution covered nationwide in the United States. Healthcare providers and patients should stop using the device immediately and follow recall instructions on the recall notice.
Baxter Healthcare Corp. recalled 12,720 CLEARLINK SYSTEM CONTINU-FLO IV sets distributed nationwide to healthcare facilities. The devices may leak during use. Hospitals and clinicians should stop using immediately and follow Baxter's recall instructions.
Northeast Scientific recalled 141 units of the NES Reprocessed 2.0mm RX Turbo Elite Laser Atherectomy Catheter nationwide in the United States. The device may have breaches in the sterile barrier packaging that could compromise sterility. Hospitals and patients should stop using the device immediately and await instructions from Northeast Scientific Inc. or their clinicians.
Granules Pharmaceuticals recalled 9,917 bottles of mixed-salts amphetamine extended-release capsules nationwide. The recall was issued August 28, 2025 and remains active. The FDA cited failed impurities/degradation specifications as the reason. Healthcare providers and consumers should stop using the product immediately and contact Granules Pharmaceuticals for guidance.
DT Swiss recalled carbon road wheels sold aftermarket and on high-end bikes due to a wheel integrity defect that can cause a crash. The recall covers wheels with DT Swiss ID codes of 2740000 or higher. DT Swiss provided a replacement remedy. Consumers should stop riding recalled wheels and contact DT Swiss for a replacement.
Granules Pharmaceuticals recalled 11,928 bottles of an extended-release amphetamine product. The recall date is 2025-08-28 for Dextroamphetamine saccharate and related salts. The FDA lists the reason as failed impurities and degradation specifications. The recall remains active as of 2025-10-01. Health care providers and patients should stop use and contact the manufacturer for guidance.
Granules Pharmaceuticals Inc. recalls 3,384 bottles of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, 100 capsules per bottle, NDC 70010-029-01, Lot GPC250158A, Exp 06-22-2027. The recall concerns failed impurities/degradation specifications. Healthcare providers and consumers should stop using the
Granules Pharmaceuticals recalled 11,895 bottles of an extended-release amphetamine product due to failed impurities and degradation specifications. The recall is active nationwide in the United States. The FDA notice lists a high hazard level and urges stop-use and contact with the company or a healthcare provider.